| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 47.16 | -0.17 (-0.36%) | 37.02 - 48.79 | 15.8 million (Below Avg) |
Market data as of 4:00PM 05/24/13. Quotes are delayed by at least 15 min.
Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine
05/23/2013 5:00 PM ET
Merck Statement on FDA Advisory Committee Meeting for Suvorexant
05/22/2013 6:28 PM ET
Merck Announces $5 Billion Accelerated Share Repurchase
05/21/2013 5:00 PM ET